Combining neurotrophin-transduced Schwann cells and rolipram to promote functional recovery from subacute spinal cord injury

Govinder Flora, Gravil Joseph, Samik Patel, Amanpreet Singh, Drew Bleicher, David J. Barakat, Jack Louro, Stephanie Fenton, Maneesh Garg, Mary B Bunge, Damien D Pearse

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Following spinal cord injury (SCI), both an inhibitory environment and lack of intrinsic growth capacity impede axonal regeneration. In a previous study, prevention of cyclic adenosine monophosphate (AMP) hydrolysis by the phosphodiesterase-4 inhibitor rolipram, in combination with Schwann cell (SC) grafts, promoted significant supraspinal and proprioceptive fiber growth and/or sparing and improved locomotion. In another study, transplanted SCs transduced to generate a bifunctional neurotrophin (D15A) led to significant increases in graft SCs and axons, including supraspinal and myelinated axons. Here we studied the growth and myelination of local and supraspinal axons and functional outcome following the combination of rolipram administration and neurotrophin-transduced SC implantation after SCI. Rolipram was administered subcutaneously for 4 weeks immediately after contusion at vertebral T8 (25.0-mm weight drop, MASCIS impactor). GFP or GFP-D15A-transduced SCs were injected into the injury epicenter 1 week after SCI. GFP-D15A SC grafts and GFP SC grafts with rolipram contained significantly more serotonergic fibers compared to GFP SCs. SC myelinated axons were increased significantly in GFP SC with rolipram-treated animals compared to animals receiving SCI alone. Rolipram administered with either GFP or GFP-D15A SCs significantly increased numbers of brain stem-derived axons below the lesion/implant area and improved hindlimb function. Compared to the single treatments, the combination led to the largest SC grafts, the highest numbers of serotonergic fibers in the grafts, and increased numbers of axons from the reticular formation below the lesion/implant area and provided the greatest improvement in hindlimb function. These findings demonstrate the therapeutic potential for a combination therapy involving the maintenance of cyclic AMP levels and neurotrophin-transduced SCs to repair the subacutely injured spinal cord.

Original languageEnglish
Pages (from-to)2203-2217
Number of pages15
JournalCell Transplantation
Volume22
Issue number12
DOIs
StatePublished - Dec 19 2013

Fingerprint

Rolipram
Schwann Cells
Nerve Growth Factors
Spinal Cord Injuries
Grafts
Axons
Cells
Recovery
Transplants
Hindlimb
Fibers
Animals
Cyclic AMP
Growth
Phosphodiesterase 4 Inhibitors
Reticular Formation
Contusions
Locomotion
Hydrolysis
Brain

Keywords

  • Axonal growth
  • Brain-derived neurotrophic factor (BDNF)
  • Cyclic adenosine monophosphate (AMP)
  • Myelination
  • Neurotrophin-3 (NT-3)
  • Proprioceptive fiber growth
  • Supraspinal axons
  • Viral vector

ASJC Scopus subject areas

  • Cell Biology
  • Transplantation
  • Biomedical Engineering

Cite this

Combining neurotrophin-transduced Schwann cells and rolipram to promote functional recovery from subacute spinal cord injury. / Flora, Govinder; Joseph, Gravil; Patel, Samik; Singh, Amanpreet; Bleicher, Drew; Barakat, David J.; Louro, Jack; Fenton, Stephanie; Garg, Maneesh; Bunge, Mary B; Pearse, Damien D.

In: Cell Transplantation, Vol. 22, No. 12, 19.12.2013, p. 2203-2217.

Research output: Contribution to journalArticle

Flora, G, Joseph, G, Patel, S, Singh, A, Bleicher, D, Barakat, DJ, Louro, J, Fenton, S, Garg, M, Bunge, MB & Pearse, DD 2013, 'Combining neurotrophin-transduced Schwann cells and rolipram to promote functional recovery from subacute spinal cord injury', Cell Transplantation, vol. 22, no. 12, pp. 2203-2217. https://doi.org/10.3727/096368912X658872
Flora, Govinder ; Joseph, Gravil ; Patel, Samik ; Singh, Amanpreet ; Bleicher, Drew ; Barakat, David J. ; Louro, Jack ; Fenton, Stephanie ; Garg, Maneesh ; Bunge, Mary B ; Pearse, Damien D. / Combining neurotrophin-transduced Schwann cells and rolipram to promote functional recovery from subacute spinal cord injury. In: Cell Transplantation. 2013 ; Vol. 22, No. 12. pp. 2203-2217.
@article{afd4801a7d86499080eb3ff4724c8197,
title = "Combining neurotrophin-transduced Schwann cells and rolipram to promote functional recovery from subacute spinal cord injury",
abstract = "Following spinal cord injury (SCI), both an inhibitory environment and lack of intrinsic growth capacity impede axonal regeneration. In a previous study, prevention of cyclic adenosine monophosphate (AMP) hydrolysis by the phosphodiesterase-4 inhibitor rolipram, in combination with Schwann cell (SC) grafts, promoted significant supraspinal and proprioceptive fiber growth and/or sparing and improved locomotion. In another study, transplanted SCs transduced to generate a bifunctional neurotrophin (D15A) led to significant increases in graft SCs and axons, including supraspinal and myelinated axons. Here we studied the growth and myelination of local and supraspinal axons and functional outcome following the combination of rolipram administration and neurotrophin-transduced SC implantation after SCI. Rolipram was administered subcutaneously for 4 weeks immediately after contusion at vertebral T8 (25.0-mm weight drop, MASCIS impactor). GFP or GFP-D15A-transduced SCs were injected into the injury epicenter 1 week after SCI. GFP-D15A SC grafts and GFP SC grafts with rolipram contained significantly more serotonergic fibers compared to GFP SCs. SC myelinated axons were increased significantly in GFP SC with rolipram-treated animals compared to animals receiving SCI alone. Rolipram administered with either GFP or GFP-D15A SCs significantly increased numbers of brain stem-derived axons below the lesion/implant area and improved hindlimb function. Compared to the single treatments, the combination led to the largest SC grafts, the highest numbers of serotonergic fibers in the grafts, and increased numbers of axons from the reticular formation below the lesion/implant area and provided the greatest improvement in hindlimb function. These findings demonstrate the therapeutic potential for a combination therapy involving the maintenance of cyclic AMP levels and neurotrophin-transduced SCs to repair the subacutely injured spinal cord.",
keywords = "Axonal growth, Brain-derived neurotrophic factor (BDNF), Cyclic adenosine monophosphate (AMP), Myelination, Neurotrophin-3 (NT-3), Proprioceptive fiber growth, Supraspinal axons, Viral vector",
author = "Govinder Flora and Gravil Joseph and Samik Patel and Amanpreet Singh and Drew Bleicher and Barakat, {David J.} and Jack Louro and Stephanie Fenton and Maneesh Garg and Bunge, {Mary B} and Pearse, {Damien D}",
year = "2013",
month = "12",
day = "19",
doi = "10.3727/096368912X658872",
language = "English",
volume = "22",
pages = "2203--2217",
journal = "Cell Transplantation",
issn = "0963-6897",
publisher = "Cognizant Communication Corporation",
number = "12",

}

TY - JOUR

T1 - Combining neurotrophin-transduced Schwann cells and rolipram to promote functional recovery from subacute spinal cord injury

AU - Flora, Govinder

AU - Joseph, Gravil

AU - Patel, Samik

AU - Singh, Amanpreet

AU - Bleicher, Drew

AU - Barakat, David J.

AU - Louro, Jack

AU - Fenton, Stephanie

AU - Garg, Maneesh

AU - Bunge, Mary B

AU - Pearse, Damien D

PY - 2013/12/19

Y1 - 2013/12/19

N2 - Following spinal cord injury (SCI), both an inhibitory environment and lack of intrinsic growth capacity impede axonal regeneration. In a previous study, prevention of cyclic adenosine monophosphate (AMP) hydrolysis by the phosphodiesterase-4 inhibitor rolipram, in combination with Schwann cell (SC) grafts, promoted significant supraspinal and proprioceptive fiber growth and/or sparing and improved locomotion. In another study, transplanted SCs transduced to generate a bifunctional neurotrophin (D15A) led to significant increases in graft SCs and axons, including supraspinal and myelinated axons. Here we studied the growth and myelination of local and supraspinal axons and functional outcome following the combination of rolipram administration and neurotrophin-transduced SC implantation after SCI. Rolipram was administered subcutaneously for 4 weeks immediately after contusion at vertebral T8 (25.0-mm weight drop, MASCIS impactor). GFP or GFP-D15A-transduced SCs were injected into the injury epicenter 1 week after SCI. GFP-D15A SC grafts and GFP SC grafts with rolipram contained significantly more serotonergic fibers compared to GFP SCs. SC myelinated axons were increased significantly in GFP SC with rolipram-treated animals compared to animals receiving SCI alone. Rolipram administered with either GFP or GFP-D15A SCs significantly increased numbers of brain stem-derived axons below the lesion/implant area and improved hindlimb function. Compared to the single treatments, the combination led to the largest SC grafts, the highest numbers of serotonergic fibers in the grafts, and increased numbers of axons from the reticular formation below the lesion/implant area and provided the greatest improvement in hindlimb function. These findings demonstrate the therapeutic potential for a combination therapy involving the maintenance of cyclic AMP levels and neurotrophin-transduced SCs to repair the subacutely injured spinal cord.

AB - Following spinal cord injury (SCI), both an inhibitory environment and lack of intrinsic growth capacity impede axonal regeneration. In a previous study, prevention of cyclic adenosine monophosphate (AMP) hydrolysis by the phosphodiesterase-4 inhibitor rolipram, in combination with Schwann cell (SC) grafts, promoted significant supraspinal and proprioceptive fiber growth and/or sparing and improved locomotion. In another study, transplanted SCs transduced to generate a bifunctional neurotrophin (D15A) led to significant increases in graft SCs and axons, including supraspinal and myelinated axons. Here we studied the growth and myelination of local and supraspinal axons and functional outcome following the combination of rolipram administration and neurotrophin-transduced SC implantation after SCI. Rolipram was administered subcutaneously for 4 weeks immediately after contusion at vertebral T8 (25.0-mm weight drop, MASCIS impactor). GFP or GFP-D15A-transduced SCs were injected into the injury epicenter 1 week after SCI. GFP-D15A SC grafts and GFP SC grafts with rolipram contained significantly more serotonergic fibers compared to GFP SCs. SC myelinated axons were increased significantly in GFP SC with rolipram-treated animals compared to animals receiving SCI alone. Rolipram administered with either GFP or GFP-D15A SCs significantly increased numbers of brain stem-derived axons below the lesion/implant area and improved hindlimb function. Compared to the single treatments, the combination led to the largest SC grafts, the highest numbers of serotonergic fibers in the grafts, and increased numbers of axons from the reticular formation below the lesion/implant area and provided the greatest improvement in hindlimb function. These findings demonstrate the therapeutic potential for a combination therapy involving the maintenance of cyclic AMP levels and neurotrophin-transduced SCs to repair the subacutely injured spinal cord.

KW - Axonal growth

KW - Brain-derived neurotrophic factor (BDNF)

KW - Cyclic adenosine monophosphate (AMP)

KW - Myelination

KW - Neurotrophin-3 (NT-3)

KW - Proprioceptive fiber growth

KW - Supraspinal axons

KW - Viral vector

UR - http://www.scopus.com/inward/record.url?scp=84890321394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890321394&partnerID=8YFLogxK

U2 - 10.3727/096368912X658872

DO - 10.3727/096368912X658872

M3 - Article

C2 - 23146351

AN - SCOPUS:84890321394

VL - 22

SP - 2203

EP - 2217

JO - Cell Transplantation

JF - Cell Transplantation

SN - 0963-6897

IS - 12

ER -